Clinical Trial: A Phase 1, First-in-human Study of VX-668
Study Status: Completed
Recruit Status: RECRUITING
Condition: Alpha-1 Antitrypsin Deficiency
Study Type: INTERVENTIONAL
Official Title: A Phase 1, First-in-human Study of Safety, Tolerability, and Pharmacokinetics of VX-668
Brief Summary:
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-668 at various doses.
Read more